Homozygous mutations in PARK2 (encoding parkin, an E3 ubiquitin ligase) are known to cause early-onset forms of Parkinson disease (68) and the association of heterozygous variants with an increased risk of PD has long been debated. Here, PRKN is linked to Parkinson disease.